AMGN · Amgen Inc.
AI read · Good for AMGN
The AI's read
That gives Amgen evidence that the drug can help people with this disease, which has no U.S.-approved treatment. The study also found less dryness with one dose schedule. The drug is still being studied in another group of patients, and it is not yet an approved treatment. The positive results support Amgen's outlook, but they do not guarantee the drug will reach patients.